On the other hand, given that long-term GluOC administration induces insulin resistance in male mice because of an increase in circulating testosterone levels (14), it is likely that additional treatment with GluOC would be a more deteriorative additive to GPRC6A ablation. The gene discussed is GPRC6A; the disease is Insulin resistance.